Prof. Dr. Paulo M. Hoff, Prof. Dr. Luisa Lina Villa, and Dr. Renata Bonadio won in different categories.
The Professional Master’s Program in Innovation and Evaluation of Technologies in Cancerology, based at the São Paulo State Cancer Institute (ICESP) and affiliated with the Faculdade de Medicina da Universidade de São Paulo (FMUSP), is accepting applications until January 30, 2026.
The Faculdade de Medicina da Universidade de São Paulo (FMUSP) is holding a public examination for the position of Assistant Professor in the Department of Radiology and Oncology, in the field of Medical Physics, under the Full-Time Teaching and Research Regime (RDIDP), with a salary of R$ 16,353.01.
The Comprehensive Center for Precision Oncology (C2PO) at the University of São Paulo (USP) is accepting applications for four postdoctoral fellowship positions aimed at researchers interested in advancing precision oncology. The fellowships cover different research areas and reflect the Center’s interdisciplinary nature.
Held from September 15 to 19, 2025, the training brought together South American researchers for theoretical and practical activities, as well as an international symposium on the topic.
The event discussed prevention, lifestyle habits, research advances, and challenges in cancer treatment within the SUS.
The event featured an introductory course, thematic sessions, scientific presentations, and a tribute to Prof. Luisa Villa, a pioneer in HPV research.
In its 16th edition, the award honored scientists from USP, the Hospital de Câncer de Barretos, and oncologist Maria Paula Curado from A.C. Camargo Cancer Center for their decisive contributions to the fight against cancer.
Activity organized by master’s and doctoral students featured theoretical and practical modules and participation from researchers at the Center for Translational Research in Oncology.
New policy enhances the strategic use of data, strengthens information security, and fosters innovation at the largest hospital complex in Latin America.
Episode discusses lung cancer and the dangers of smoking and vaping.
The research combines nanotechnology and gene therapy with the goal of restoring the effectiveness of temozolomide, the main drug used in the treatment of glioblastoma. The work involves researchers from IPT and several other Brazilian institutions.